Advanced Oxygen Therapy Inc.
$115.1K 1,314 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Eko Health, Inc.
Eko Health, Inc. reported $115,464.08 across General Payments, Research, and Ownership to 121 physicians and teaching hospitals across 121 transactions.
- $115.5K Below-median payer
- All-tracks total
- 121 Below-median volume
- Transactions
- 121 Below-median reach
- Recipients
- +$77.3K
- General Payments vs PY2023
Eko Health, Inc. reported $115,464.08 across all CMS Open Payments tracks (General + Research + Ownership) to 121 physicians and teaching hospitals in Program Year 2024 - ranking #1149 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $115,464.08, averaging $954.25 per recipient.
Eko Health, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
24/100
Total payments
F
11/100
Transaction volume
F
11/100
Physician reach
F
11/100
Payment type diversity
D
63/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer eko-health-inc Eko Health, Inc.
$115.5K · #1149/1,925 · 0.0% industry · PY2024
- TOT $115.5K
- RANK #1149
- SHARE 0.0%
- TXN 121
- RCP 121
- CAT 5
- GEN $115.5K
- ΔGEN +$77.3K
- TOP1 74.2%
- PY 2024
Volume peers
Nearest volume peer: Advanced Oxygen Therapy Inc. ($115.1K)
Eko Health, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Eko Health, Inc.'s CMS-reported General Payments increased by $77.3K (+202.2%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: EKO HEALTH, INC.PY2023: EKO HEALTH, INC.PY2024: Eko Health, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $38,213.47
- PY2024
- $115,464.08
What the Data Shows for Eko Health, Inc.
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Eko Health, Inc. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
Of the 5 general-payment categories charted below, "Consulting Fee" is the largest at $85.8K across 12 transactions, 74.3% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Eko Health, Inc. made 5 types of general payments. "Consulting Fee" is the largest category at $85.8K, 74.3% of General Payments.
Eko Health, Inc. reports 5 general-payment categories - the top three are Consulting Fee (74.3%), Compensation for Services Other Than Consulting (13.5%), and Long-Term Medical Supply or Device Loan (9.5%). The remaining 2 categories make up 2.7% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Eko Health, Inc. divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $85.8K | 12 | 74.3% |
| Compensation for Services Other Than Consulting | $15.6K | 73 | 13.5% |
| Long-Term Medical Supply or Device Loan | $11.0K | 23 | 9.5% |
| Travel and Lodging | $1.7K | 1 | 1.5% |
| Food and Beverage | $1.4K | 12 | 1.2% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $91,514.01 (79.3%) of $115,464.08 in this company's General Payments records across 101 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Eko Health, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Steven Steinhubl
$85,667.01 across 13 reported transactions
- 2
Joy Wang
$2,300.00 across 4 reported transactions
- 3
Nicholas Slamon
$1,347.00 across 1 reported transactions
- 4
Joanna Kmiecik
$1,200.00 across 2 reported transactions
- 5
Anita Singh
$1,000.00 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Eko Health, Inc. ranks #1149 of 1,925 by total payments (bottom 40% by spend) but is notably more concentrated than that alone would suggest -- #300 of 1,838 by HHI (top 16% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- BlueRock Therapeutics LP : $405.9K total payments, HHI 5593
- Nidek Co., Ltd. : $29.8K total payments, HHI 5592
- DiaSorin Inc. : $371.5K total payments, HHI 5574
- Bavarian Nordic A/S : $68.0K total payments, HHI 5563
- Mindera Corp : $7.5K total payments, HHI 5556
- Ferring International Pharmascience Center US : $282.61 total payments, HHI 5546
- Eko Health, Inc. (this company) : $115.5K total payments, HHI 5521
- Maquet Critical Care AB : $2.6K total payments, HHI 5476
- Theragenics Corporation : $135.5K total payments, HHI 5468
- Orpyx Medical Technologies Inc. : $5.8K total payments, HHI 5463
- OraBio, Inc. : $98.2K total payments, HHI 5429
- Vascular Technology, Inc. : $943.2K total payments, HHI 5399
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Eko Health, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Eko Health, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Eko Health, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Ferring International Pharmascience Center US
$116.6K 3 recipients
Compare payment profiles
Linde Gas & Equipment Inc.
$116.7K 348 recipients
Compare payment profiles
Reprise Biomedical, Inc.
$117.0K 1,101 recipients
Compare payment profiles
Caldera Medical, Inc
$117.1K 1,085 recipients
Compare payment profiles
Jan Medical Inc.
$117.5K 6 recipients
Compare payment profiles
Put this to use
Eko Health, Inc. ranks #1149 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Eko Health, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.